Results 61 to 70 of about 9,189 (154)

An Exploratory Cost‐Utility Analysis of Screening and Treating Immigrants in Canada for Hepatitis D

Journal of Viral Hepatitis, Volume 33, Issue 8, August 2026.
ABSTRACT Hepatitis D is common among immigrants in Canada, who account for approximately 23% of the population and tend to originate from high‐endemic countries. Mortality rates are notably high among those with chronic infections, and immigrants are less likely to engage in screening and treatment services.
Jiahao Zhao, Diedron Lewis, John‐Michael Gamble, Zahid A. Butt, William W. L. Wong   +4 more
wiley   +1 more source

From Diagnosis to Durability: A Review of the European Bulevirtide Experience and Practical Learnings for CHD Management

Liver International, Volume 46, Issue 8, August 2026.
ABSTRACT Hepatitis delta virus (HDV) infection causes chronic hepatitis D (CHD), the most severe form of chronic viral hepatitis with a high risk of progression to advanced liver disease. Off‐label pegylated interferon alpha was the primary treatment option in Europe prior to the introduction of bulevirtide, a first‐in‐class HDV entry inhibitor.
Monica Radu, Margarita Papatheodoridi, Habiba Kamal Khodir, Sabela Lens, Elisabetta Degasperi, Speranta Iacob, Liliana Gheorghe, Katja Steppich, Florin Alexandru Caruntu, Pietro Lampertico, Soo Aleman, Heiner Wedemeyer   +11 more
wiley   +1 more source

Mycobacterial cell division arrest and smooth‐to‐rough envelope transition using CRISPRi‐mediated genetic repression systems

FEBS Open Bio, Volume 16, Issue 7, Page 1271-1292, July 2026.
CRISPRI‐mediated gene silencing and phenotypic exploration in nontuberculous mycobacteria. In this Research Protocol, we describe approaches to control, monitor, and quantitatively assess CRISPRI‐mediated gene silencing in M. smegmatis and M. abscessus model organisms.
Vanessa Point, Wafaa Achache, Janïs Laudouze, Eliana Sepulveda Ramos, Mickaël Maziero, Céline Crauste, Stéphane Canaan, Pierre Santucci   +7 more
wiley   +1 more source

[The localization of delta antigen in the hepatocytes in chronic delta hepatitis].

Voprosy virusologii, 1990
The results of immunohistochemical and electron microscopic examinations of liver biopsies from 47 patients with chronic delta hepatitis are presented. Delta antigen (HDAg) was detected by immunoperoxidase method in the liver of 35 (74.4%) patients. HDAg was demonstrated in hepatocyte nucleus alone in 22 (62.9%) patients, simultaneously in the nucleus ...
A M, Dolzhanskiĭ, E S, Ketiladze, S M, Klimenko   +2 more
openaire   +1 more source

[Antigenic activity of delta-antigen peptides corresponding to three genotypes of the delta hepatitis virus].

Voprosy virusologii, 1999
Six synthetic peptides from immunodominant region 65-80 aa derived from the sequences of delta-antigen corresponding to 3 HDV genotypes were obtained. Their antigenic activities were assessed by indirect enzyme immunoassay with sera of patients with hepatitis D and of asymptomatic carriers of anti-delta antibodies.
E V, Dement'eva, I V, Kruglov, V K, Pimenov, Iu A, Semiletov   +3 more
openaire   +1 more source

Dried Blood Spot: A Tool to Ensure Broad Access to Hepatitis D Screening, Diagnosis, and Treatment Monitoring. [PDF]

Liver Int
Matar R, Roudot-Thoraval F, Ortonne V, Garrigou O, Soulier A, Cappy P, Candotti D, Ingiliz P, Pawlotsky JM, Leroy V, Chevaliez S.   +10 more
europepmc   +1 more source

A replication-competent deltavirus from the marsupial fat-tailed dunnart <i>Sminthopsis crassicaudata</i>. [PDF]

J Gen Virol
Denis Z, Courgnaud V, de la Peña M, Majzoub K.   +3 more
europepmc   +1 more source

Hepatitis (D)Delta-Antigen [PDF]

, 2019
openaire   +1 more source

Epidemiology of hepatitis D virus coinfection among HBsAg-positive individuals in Kermanshah, Western Iran. [PDF]

GMS Hyg Infect Control
Khodaei N, Shahbazi S, Pirvesi M, Zobeiri M, Sayad B, Rezvani N, Shirvani M.   +6 more
europepmc   +1 more source

Woodchuck and deer Hepatitis Delta-like agents show distinct innate immune activation and IFN-resistance compared to human Hepatitis D Virus. [PDF]

Sci Rep
Gnouamozi GE, Kooij AC, Schrimpf MR, Zehnder B, Zhang Z, Urban S.   +5 more
europepmc   +1 more source